Teikoku Seiyaku Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Teikoku Seiyaku Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3341
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Teikoku Seiyaku Co Ltd (Teikoku Seiyaku) is a medical device company that develops, manufactures and distributes medicated and medically related supplies. The company offers Chinese medicine, other medicinal products, quasi-drugs, cosmetics, hot sensation plaster, transdermal indomethacin medicated plaster for prescription use, felbinac medicated plaster and lidocaine medicated plaster. Its products are used in healthcare organizations. Teikoku Seiyaku operates laboratories, production plants and sales offices in Tokushima, Tokyo and Osaka, among others. The company has operations in China and the US. It operates through its offices in Chuo-ku, Awa, and Higashikagawa, Japan. Teikoku Seiyaku is headquartered in Higashikagawa, Japan.

Teikoku Seiyaku Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Teikoku Seiyaku Enters into Agreement with Mitsubishi Tanabe Pharma 10
Dainippon Sumitomo Pharma Enters into Co-Marketing Agreement with Teikoku Seiyaku 11
Licensing Agreements 13
Link Health Enters into Licensing Agreement Teikoku Pharma 13
Eagle Pharma Enters into Licensing Agreement with Teikoku Pharma 14
Uriach Enters into Licensing Agreement with Teikoku Seiyaku for Rupatadine 15
Teikoku Seiyaku Co Ltd – Key Competitors 16
Teikoku Seiyaku Co Ltd – Key Employees 17
Teikoku Seiyaku Co Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Teikoku Seiyaku Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Teikoku Seiyaku Enters into Agreement with Mitsubishi Tanabe Pharma 10
Dainippon Sumitomo Pharma Enters into Co-Marketing Agreement with Teikoku Seiyaku 11
Link Health Enters into Licensing Agreement Teikoku Pharma 13
Eagle Pharma Enters into Licensing Agreement with Teikoku Pharma 14
Uriach Enters into Licensing Agreement with Teikoku Seiyaku for Rupatadine 15
Teikoku Seiyaku Co Ltd, Key Competitors 16
Teikoku Seiyaku Co Ltd, Key Employees 17
Teikoku Seiyaku Co Ltd, Other Locations 18
Teikoku Seiyaku Co Ltd, Subsidiaries 19

List of Figures
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Teikoku Seiyaku Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Teikoku Seiyaku Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Xped Ltd (XPE):企業の財務・戦略的SWOT分析
    Xped Ltd (XPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Petro Vista Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Petro Vista Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Petro Vista Energy Corp (Petro Vista) is an oil and gas company that offers oil and gas exploration and development services. The company offers acquisition, development, exploration, and product …
  • Tongaat Hulett Ltd (TON):企業の財務・戦略的SWOT分析
    Tongaat Hulett Ltd (TON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Enerjisa Enerji AS:電力:M&Aディール及び事業提携情報
    Summary Enerjisa Enerji AS (Enerjisa Enerji) is a power generation company. The company operates in the business of distribution, and sale of electricity. It provides electricity wholesale and retail services, marketing, products and services development, energy management, and energy consultancy se …
  • EyeGate Pharmaceuticals Inc (EYEG):医療機器:M&Aディール及び事業提携情報
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontop …
  • Hargreaves Services Plc:企業の戦略・SWOT・財務分析
    Hargreaves Services Plc - Strategy, SWOT and Corporate Finance Report Summary Hargreaves Services Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Oil and Natural Gas Corporation Ltd (ONGC)-エネルギー分野:企業M&A・提携分析
    Summary Oil and Natural Gas Corporation Ltd (ONGC) is an integrated oil and gas company. It explores for and produces oil and natural gas; refines crude oil; and markets and distributes petroleum products. The company's product portfolio includes crude oil, natural gas, liquefied natural gas, naphth …
  • Olin Corporation
    Olin Corporation - Strategy, SWOT and Corporate Finance Report Summary Olin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Newfield Exploration Company:戦略・SWOT・企業財務分析
    Newfield Exploration Company - Strategy, SWOT and Corporate Finance Report Summary Newfield Exploration Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Emirates Retakaful Limited:企業の戦略・SWOT・財務情報
    Emirates Retakaful Limited - Strategy, SWOT and Corporate Finance Report Summary Emirates Retakaful Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Shenergy Co., Ltd. (600642):電力:M&Aディール及び事業提携情報
    Summary Shenergy Company, Ltd. (Shenergy) is China-based gas and electricity company. The company is engaged in the construction, investment, operations and management of petroleum, natural gas and electric power. Its electricity projects include hydropower, coal-fired power and thermal power genera …
  • Ultradent Products Inc:企業の戦略的SWOT分析
    Ultradent Products Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Collagen Solutions Plc (COS):製品パイプライン分析
    Summary Collagen Solutions Plc (Collagen Solutions), formerly Healthcare Investment Opportunities Plc is a medical device company that develops, manufactures and supplies medical grade collagen biomaterials and components. The company offers sourcing and supply of high grade collagen; provision of f …
  • Stryker Corp (SYK):企業の財務・戦略的SWOT分析
    Stryker Corp (SYK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Luigi Lavazza S.p.A.:企業の戦略・SWOT・財務情報
    Luigi Lavazza S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Luigi Lavazza S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Air Transport Services Group, Inc.:企業の戦略・SWOT・財務情報
    Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Hidd Power Company:企業の戦略的SWOT分析
    Hidd Power Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Regeneron Pharmaceuticals Inc (REGN):企業の製品パイプライン分析
    Summary Regeneron Pharmaceuticals Inc (Regeneron) discovers, develops, manufactures, and markets medicines for the treatment of serious medical conditions. Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, meta …
  • Dover Corporation:企業の戦略・SWOT・財務分析
    Dover Corporation - Strategy, SWOT and Corporate Finance Report Summary Dover Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Avalon Oil & Gas Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Avalon Oil & Gas Inc (Avalon), formerly Snow Runner (USA) Inc is an oil and gas company that develops and operates crude oil and natural gas properties. The company acquires, produces and develops oil and natural gas reserves. It offers reservoir maintenance and technologies to produce portf …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆